Skip to main content
Year archive

Xvivo Perfusion — 2026 filings

All 14 regulatory filings released by Xvivo Perfusion (XVIVO) in 2026, sourced directly from the official regulator.

14 Filings
2026 Period
2026 filings (14)
Filing Released Lang
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2026-04-27 English
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
AGM Information
2026-04-27 Swedish
Preliminary one-year follow-up data from the US PRESERVE trial for XVIVO’s heart technology presented at ISHLT in Toronto
Regulatory Filings
2026-04-22 English
Preliminära ettårsuppföljningsdata från den amerikanska PRESERVE-studien för XVIVOs hjärtteknologi presenterade på ISHLT i Toronto
Regulatory Filings
2026-04-22 Swedish
Annual Report (ESEF) 2025
Annual Report (ESEF) FY 2025
2026-04-01 Swedish
Annual Report (ESEF) 2025
Annual Report (ESEF) FY 2025
2026-04-01 Swedish
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN XVIVO PERFUSION AB (PUBL)
Proxy Solicitation & Information Statement
2026-03-19 English
KALLELSE TILL ÅRSSTÄMMA I XVIVO PERFUSION AB (PUBL)
Proxy Solicitation & Information Statement
2026-03-19 Swedish
Correction: The Nomination Committee’s proposal for new board members
Board/Management Information
2026-02-20 English
Rättelse: Valberedningens förslag till nya styrelseledamöter
Regulatory Filings
2026-02-20 Swedish
The Nomination Committee of XVIVO Perfusion AB (publ) proposes Emil Billbäck and Anne-Karen Hunt as new members of the Board of Directors
Board/Management Information
2026-02-20 English
Valberedningen för XVIVO Perfusion AB (publ) föreslår Emil Billbäck samt Anne-Karen Hunt till nya styrelseledamöter
Regulatory Filings
2026-02-20 Swedish
Earnings Release 2025
Earnings Release Q4 2025
2026-01-27 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Q4 2025
2026-01-27 English